|
WO2009144554A1
(en)
|
2008-05-28 |
2009-12-03 |
Pfizer, Inc. |
Pyrazolospiroketone acetyl-c0a carboxylase inhibitors
|
|
PT2499139E
(pt)
*
|
2009-11-10 |
2014-02-10 |
Pfizer |
Inibidores de n1-pirazolospirocetona acetil-coa carboxilase
|
|
PL2547679T3
(pl)
|
2010-03-19 |
2016-02-29 |
Pfizer |
Pochodne 2,3-dihydro-1H-inden-1-ylo-2,7-diazaspiro[3.5]nonanu i ich zastosowanie jako antagonistów lub odwrotnych agonistów receptora greliny
|
|
US9006450B2
(en)
|
2010-07-01 |
2015-04-14 |
Boehringer Ingelheim International Gmbh |
Compounds, pharmaceutical compositions and uses thereof
|
|
HRP20161178T1
(hr)
|
2010-09-30 |
2016-11-04 |
Pfizer Inc. |
N1-PIRAZOLOSPIROKETONSKI INHIBITORI ACETIL-CoA-KARBOKSILAZE
|
|
HUE025078T2
(en)
*
|
2010-10-29 |
2016-01-28 |
Pfizer |
N1 / N2-lactam-acetyl-CoA carboxylase inhibitors
|
|
PE20141187A1
(es)
|
2011-04-22 |
2014-09-18 |
Pfizer |
Inhibidores sustituidos de aeitl-coa carboxilasa
|
|
CA2841757A1
(en)
|
2011-07-15 |
2013-01-24 |
Etzer Darout |
Gpr 119 modulators
|
|
RU2013157388A
(ru)
|
2011-07-22 |
2015-08-27 |
Пфайзер Инк. |
Хинолинильные модуляторы глюкагонового рецептора
|
|
JP6043355B2
(ja)
|
2011-08-31 |
2016-12-14 |
ファイザー・インク |
ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
GEP201706656B
(en)
|
2011-11-11 |
2017-04-25 |
Pfizer |
2-thiopyrimidinones
|
|
SG11201405477XA
(en)
|
2012-04-06 |
2014-11-27 |
Pfizer |
Diacylglycerol acyltransferase 2 inhibitors
|
|
US8889730B2
(en)
|
2012-04-10 |
2014-11-18 |
Pfizer Inc. |
Indole and indazole compounds that activate AMPK
|
|
ES2585262T3
(es)
|
2012-05-04 |
2016-10-04 |
Pfizer Inc |
Compuestos heterocíclicos de hexahidropiran[3,4-d][1,3]tiazin-2-amina sustituidos como inhibidores de PPA, BACE1 y BACE2
|
|
CA2882389A1
(en)
|
2012-09-20 |
2014-03-27 |
Pfizer Inc. |
Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
WO2014091352A1
(en)
|
2012-12-11 |
2014-06-19 |
Pfizer Inc. |
Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
|
|
CA2893333C
(en)
|
2012-12-19 |
2017-10-24 |
Pfizer Inc. |
Carbocyclic-and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
WO2014125394A1
(en)
|
2013-02-13 |
2014-08-21 |
Pfizer Inc. |
HETEROARYL-SUBSTITUTED HEXAHYDROPYRANO [3,4-d][1,3] THIAZIN-2-AMINE COMPOUNDS
|
|
US9233981B1
(en)
|
2013-02-15 |
2016-01-12 |
Pfizer Inc. |
Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
BR112016004118A2
(pt)
|
2013-09-12 |
2017-10-17 |
Pfizer |
uso de inibidores da acetil-coa carboxilase para tratamento de acne vulgar
|
|
JP6348582B2
(ja)
|
2013-10-09 |
2018-06-27 |
ファイザー・インク |
プロスタグランジンｅｐ３受容体の拮抗薬
|
|
EP3119757B1
(en)
|
2014-03-17 |
2018-05-16 |
Pfizer Inc |
Diacylglycerol acyltransferase 2 inhibitors for use in the treatment of metabolic and related disorders
|
|
WO2015150995A1
(en)
|
2014-04-04 |
2015-10-08 |
Pfizer Inc. |
Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors
|
|
CR20160455A
(es)
|
2014-04-10 |
2016-12-16 |
Pfizer |
2-AMINO-6-METIL-4,4a,5,6-TETRAHIDROPIRANO[3,4-d][1,3]TIAZIN-8a(8H)-IL-1,3-TIAZOL-4-ILA
|
|
EP3194367B1
(en)
*
|
2014-09-17 |
2021-08-18 |
Boehringer Ingelheim International GmbH |
Tetrahydroisoquinoline derivatives and pharmaceutical compositions useful for the treatment of obesity and diabetes
|
|
WO2016092413A1
(en)
|
2014-12-10 |
2016-06-16 |
Pfizer Inc. |
Indole and indazole compounds that activate ampk
|
|
EP3237401B1
(en)
|
2014-12-22 |
2019-03-06 |
Pfizer Inc |
Antagonists of prostaglandin ep3 receptor
|
|
MA42035A
(fr)
|
2015-05-05 |
2018-03-14 |
Pfizer |
2-thiopyrimidinones
|
|
US10308615B2
(en)
|
2015-05-29 |
2019-06-04 |
Pfizer Inc. |
Heterocyclic compounds as inhibitors of Vanin-1 enzyme
|
|
ES2832893T3
(es)
|
2015-06-17 |
2021-06-11 |
Pfizer |
Compuestos tricíclicos y su uso como inhibidores de la fosfodiesterasa
|
|
WO2016203335A1
(en)
|
2015-06-18 |
2016-12-22 |
Pfizer Inc. |
Novel pyrido[2,3-b]pyrazinones as bet-family bromodomain inhibitors
|
|
AU2016305590A1
(en)
|
2015-08-13 |
2018-02-15 |
Pfizer Inc. |
Bicyclic-fused heteroaryl or aryl compounds
|
|
RS61719B1
(sr)
|
2015-08-27 |
2021-05-31 |
Pfizer |
Biciklična fuzionisana hetaroaril ili aril jedinjenja kao modulatori irak4
|
|
WO2017037567A1
(en)
|
2015-09-03 |
2017-03-09 |
Pfizer Inc. |
Regulators of frataxin
|
|
WO2017051276A1
(en)
|
2015-09-24 |
2017-03-30 |
Pfizer Inc. |
N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3] thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl] amides
|
|
EP3353174A1
(en)
|
2015-09-24 |
2018-08-01 |
Pfizer Inc |
N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2h-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl]amides useful as bace inhibitors
|
|
JP2018531924A
(ja)
|
2015-09-24 |
2018-11-01 |
ファイザー・インク |
テトラヒドロピラノ［３，４−ｄ］［１，３］オキサジン誘導体、およびｂａｃｅ阻害剤としてのその使用
|
|
JP6503515B2
(ja)
|
2015-12-29 |
2019-04-17 |
ファイザー・インク |
ケトヘキソキナーゼ阻害薬としての置換３−アザビシクロ［３．１．０］ヘキサン
|
|
JP2019519478A
(ja)
|
2016-04-19 |
2019-07-11 |
ユレカ・ソシエテ・ア・レスポンサビリテ・リミテＵｒｅｋａ Ｓａｒｌ |
ペプチド−オリゴ尿素フォルダマー化合物及びそれらの使用方法
|
|
MX2019000536A
(es)
|
2016-07-14 |
2019-04-01 |
Pfizer |
Nuevas pirimidinas carboxamidas como inhibidores de enzima vanina-1.
|
|
AR109179A1
(es)
|
2016-08-19 |
2018-11-07 |
Pfizer |
Inhibidores de diacilglicerol aciltransferasa 2
|
|
WO2019133445A1
(en)
|
2017-12-28 |
2019-07-04 |
Inception Ibd, Inc. |
Aminothiazoles as inhibitors of vanin-1
|
|
BR112021003039A2
(pt)
|
2018-08-31 |
2021-05-18 |
Pfizer Inc. |
combinações para o tratamento de nash/nafld e doenças relacionadas
|
|
WO2020102575A1
(en)
|
2018-11-16 |
2020-05-22 |
Inception Ibd, Inc. |
Heterocyclic aminothiazoles and uses thereof
|
|
WO2020163689A1
(en)
|
2019-02-08 |
2020-08-13 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
20-hete formation inhibitors
|
|
US12611401B2
(en)
|
2019-05-20 |
2026-04-28 |
Pfizer Inc. |
Combinations comprising benzodioxol as GLP-1R agonists for use in the treatment of NASH/NAFLD and related diseases
|
|
CN110922372A
(zh)
*
|
2019-11-04 |
2020-03-27 |
天津大学 |
达格列净的氨基酸共晶物及其制备方法
|
|
PE20231066A1
(es)
|
2020-02-07 |
2023-07-17 |
Gasherbrum Bio Inc |
Agonistas heterociclicos de glp-1
|
|
EP4143183B1
(en)
|
2020-04-29 |
2025-10-22 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
EP4154880A4
(en)
*
|
2020-05-21 |
2024-06-05 |
Shionogi & Co., Ltd |
Pharmaceutical for treating fatty liver diseases
|
|
JP2025509281A
(ja)
|
2022-03-09 |
2025-04-11 |
ガシャーブラム・バイオ・インコーポレイテッド |
ヘテロ環式ｇｌｐ－１アゴニスト
|
|
EP4508047A1
(en)
|
2022-04-14 |
2025-02-19 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
WO2024118524A1
(en)
|
2022-11-28 |
2024-06-06 |
Cerevel Therapeutics, Llc |
Azaindole compounds and their use as phosphodiesterase inhibitors
|
|
KR20250157491A
(ko)
|
2022-12-15 |
2025-11-04 |
가셔브룸 바이오, 인크. |
Glp-1 효능제 활성을 갖는 화합물의 염 및 고체 형태
|